FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGERContingent Value Rights Agreement • January 15th, 2020 • Aytu Bioscience, Inc • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 15th, 2020 Company Industry JurisdictionThis First Amendment to Agreement and Plan of Merger (this “First Amendment”) is entered into as of January 9, 2020 (the “Effective Date”), by and among Aytu Bioscience Inc., a Delaware corporation (“Aytu”), Innovus Pharmaceuticals, Inc., a Nevada corporation (the “Target”), and Aytu Acquisition Sub, Inc., a Delaware corporation (“Merger Sub”). Capitalized terms used but not defined herein have the meanings given to such terms in the Agreement (as defined below).
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • September 18th, 2019 • Aytu Bioscience, Inc • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 18th, 2019 Company Industry JurisdictionTHIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of ____, 2019 (this “Agreement”), is entered into by and among Aytu Bioscience Inc., a Delaware corporation (the “Company”), Vivian Liu as representative of the Holders (the “Holders’ Representative”) and ____________ (the “Rights Agent”).